Yuyin Li

1.3k total citations
50 papers, 984 citations indexed

About

Yuyin Li is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Yuyin Li has authored 50 papers receiving a total of 984 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Hematology. Recurrent topics in Yuyin Li's work include Multiple Myeloma Research and Treatments (9 papers), Ubiquitin and proteasome pathways (7 papers) and Autophagy in Disease and Therapy (7 papers). Yuyin Li is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), Ubiquitin and proteasome pathways (7 papers) and Autophagy in Disease and Therapy (7 papers). Yuyin Li collaborates with scholars based in China, United States and United Kingdom. Yuyin Li's co-authors include Aipo Diao, Long Ma, Tengteng Yu, Kenneth C. Anderson, Shih‐Feng Cho, Yu‐Tzu Tai, Liang Lin, Lijie Xing, Zhenxing Liu and Lei Jing and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Yuyin Li

49 papers receiving 975 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuyin Li China 21 617 284 173 132 119 50 984
Zhihong Wang China 22 1.2k 1.9× 237 0.8× 103 0.6× 98 0.7× 334 2.8× 81 1.6k
Ranjini K. Sundaram United States 20 557 0.9× 369 1.3× 149 0.9× 274 2.1× 165 1.4× 45 1.4k
Carmen Aanei France 12 484 0.8× 219 0.8× 185 1.1× 151 1.1× 205 1.7× 22 979
Zehavit Goldberg Israel 8 754 1.2× 387 1.4× 81 0.5× 114 0.9× 153 1.3× 15 1.2k
Gabriel Birrane United States 23 1.0k 1.7× 129 0.5× 68 0.4× 105 0.8× 152 1.3× 45 1.6k
Junxian Lim Australia 21 543 0.9× 138 0.5× 223 1.3× 275 2.1× 73 0.6× 42 1.1k
Linda Rickardson Sweden 18 705 1.1× 290 1.0× 55 0.3× 91 0.7× 219 1.8× 28 1.1k
Sarah K. Baird New Zealand 15 335 0.5× 250 0.9× 63 0.4× 113 0.9× 129 1.1× 29 850
Frida Ponthan United Kingdom 19 606 1.0× 197 0.7× 160 0.9× 112 0.8× 237 2.0× 33 1.1k

Countries citing papers authored by Yuyin Li

Since Specialization
Citations

This map shows the geographic impact of Yuyin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuyin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuyin Li more than expected).

Fields of papers citing papers by Yuyin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuyin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuyin Li. The network helps show where Yuyin Li may publish in the future.

Co-authorship network of co-authors of Yuyin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yuyin Li. A scholar is included among the top collaborators of Yuyin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuyin Li. Yuyin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Jieru E., Lu Li, Yuyin Li, et al.. (2024). The novel TFEB agonist desloratadine ameliorates hepatic steatosis by activating the autophagy-lysosome pathway. Frontiers in Pharmacology. 15. 1449178–1449178.
2.
Li, Yixuan, et al.. (2023). Efficient synthesis of (R)-4-methoxyamphetamine and its analogues under low ammonium concentration using engineered amine dehydrogenase. Molecular Catalysis. 553. 113802–113802. 1 indexed citations
3.
Yang, Yang, Lu Li, Yuyin Li, et al.. (2022). The novel prolyl hydroxylase-2 inhibitor caffeic acid upregulates hypoxia inducible factor and protects against hypoxia. European Journal of Pharmacology. 934. 175307–175307. 3 indexed citations
4.
Xing, Lijie, Su Wang, Jiye Liu, et al.. (2021). BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression. Clinical Cancer Research. 27(19). 5376–5388. 22 indexed citations
5.
Lin, Liang, Shih‐Feng Cho, Lijie Xing, et al.. (2020). Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma. Leukemia. 35(3). 752–763. 64 indexed citations
6.
Zhao, Tian, Yujie Liu, Wei Zhang, et al.. (2020). Esomeprazole inhibits the lysosomal cysteine protease legumain to prevent cancer metastasis. Investigational New Drugs. 39(2). 337–347. 11 indexed citations
7.
Zhao, Qing, Jie Pang, Yi Jiang, et al.. (2020). Production of a novel bispecific protein ULBP1×CD19-scFv targeting the NKG2D receptor and CD19 to promote the activation of NK cells. Protein Expression and Purification. 178. 105783–105783. 1 indexed citations
8.
Xing, Lijie, Liang Lin, Tengteng Yu, et al.. (2020). A novel BCMA PBD-ADC with ATM/ATR/WEE1 inhibitors or bortezomib induce synergistic lethality in multiple myeloma. Leukemia. 34(8). 2150–2162. 50 indexed citations
9.
Jing, Lei, Juanjuan Liu, Yuyin Li, et al.. (2019). Screening and production of an affibody inhibiting the interaction of the PD-1/PD-L1 immune checkpoint. Protein Expression and Purification. 166. 105520–105520. 8 indexed citations
10.
Zhao, Tian, Zhipeng Li, Ali Wang, et al.. (2018). Functional recombinant human Legumain protein expression in Pichia pastoris to enable screening for Legumain small molecule inhibitors. Protein Expression and Purification. 150. 12–16. 8 indexed citations
12.
Ma, Long, Yuanyuan Meng, Chun‐Hao Tu, et al.. (2018). A cardiac glycoside HTF-1 isolated from Helleborus thibetanus Franch displays potent in vitro anti-cancer activity via caspase-9, MAPK and PI3K-Akt-mTOR pathways. European Journal of Medicinal Chemistry. 158. 743–752. 20 indexed citations
13.
Liu, Zhenxing, Xin Huo, Shuang Zhao, et al.. (2017). Low density lipoprotein receptor class A domain containing 4 (LDLRAD4) promotes tumorigenesis of hepatic cancer cells. Experimental Cell Research. 360(2). 189–198. 15 indexed citations
14.
Li, Yuyin, Yue Chen, Tiantian Hao, et al.. (2017). Inhibitor of the human telomerase reverse trancriptase (hTERT) gene promoter induces cell apoptosis via a mitochondrial-dependent pathway. European Journal of Medicinal Chemistry. 145. 370–378. 24 indexed citations
15.
Yang, Meng, Dan Lv, Lei Jing, et al.. (2016). TMEPAI increases lysosome stability and promotes autophagy. The International Journal of Biochemistry & Cell Biology. 76. 98–106. 17 indexed citations
16.
Li, Yuyin, Jianjun Wang, Yajuan Feng, et al.. (2016). Lysosome Inhibitors Enhance the Chemotherapeutic Activity of Doxorubicin in HepG2 Cells. Chemotherapy. 62(2). 85–93. 14 indexed citations
18.
Li, Yuyin, et al.. (2015). Nedd4 E3 ubiquitin ligase promotes cell proliferation and autophagy. Cell Proliferation. 48(3). 338–347. 41 indexed citations
19.
Li, Yuyin. (2014). Effect of Isoquercetin from Fagopyrum tataricum on the Proliferation and Apoptosis of Human Gastric Carcinoma Cell Line SGC-7901. Food Science. 3 indexed citations
20.
Li, Yuyin, Yongli Bao, Zhenbo Song, et al.. (2012). The Threonine Protease Activity of Testes-Specific Protease 50 (TSP50) Is Essential for Its Function in Cell Proliferation. PLoS ONE. 7(5). e35030–e35030. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026